Plasminogen

There are 7 papers on Plasminogen in aging research: 3 trials and 3 observational studies in people, 1 in animals. The newest story, Nov 9, 2026: “Statin use linked to lower cardiovascular risk at high marker levels”.

Biomarker

7 papers study it320 more mention it2 findings

MeSH

16 new papers in 30 daysSee all 327 papers on Plasminogen

“higher expression of plasminogen (OR 2.89, 95% CI 1.14-8.81, p = 0.02) were associated with progressive LI in models simultaneously adjusted for all biomarkers.”
Postlactational involution biomarkers plasminogen and phospho-STAT3 are linked with active age-related lobular involutionBreast cancer research and treatment2017doi:10.1007/s10549-017-4413-3
  • Human trial3
  • Humans3
  • Animals1

Interventions

1

Angelica keiskei

downin mice1

1 study
  1. Angelica keiskei decreases Plasminogen in mice.

    “Supplementation with AYE decreased levels of the acute-phase and fibrinolytic protein plasma plasminogen”

    Animals52 weeks

    Supplementation with Ashitaba (Angelica keiskei) Yellow Stem Exudate Prevents Aging-Induced Thrombotic Tendencies and Systemic Inflammation Without Affecting Body Weight Gain in Mice

    Journal of medicinal food

More on Angelica keiskei

Associations

1

Progressive age-related lobular involution

upin humans1OR 2.89

1 study
  1. Plasminogen is associated with progressive age-related lobular involution in humans (Higher expression; models simultaneously adjusted for all biomarkers) (OR 2.89, 95% CI 1.14-8.81, p = 0.02).

    “higher expression of plasminogen (OR 2.89, 95% CI 1.14-8.81, p = 0.02) were associated with progressive LI in models simultaneously adjusted for all biomarkers.”

    HumansHigher expression; models simultaneously adjusted for all biomarkersbreastfemalesn = 57

    Postlactational involution biomarkers plasminogen and phospho-STAT3 are linked with active age-related lobular involution

    Breast cancer research and treatment

Funding

3 grants since 2018

National Heart, Lung, and Blood Institute$3.3MUS Department of Veterans Affairs

Latest

Dec 2025: 6Jan 2026: 6Feb 2026: 9Mar 2026: 8Apr 2026: 5May 2026: 7Jun 2026: 3Jul 2026: 4Aug 2026: 7Sep 2026: 5Oct 2026: 8Nov 2026: 977 papers in 12 months
AHA Scientific Sessions 2026 Abstract

Statin use linked to lower cardiovascular risk at high marker levels

Compared with nonuse, statin use was linked to a 35% lower relative cardiovascular event rate in adults in the highest third for an inflammation marker.Compared with nonuse, statin use was linked to a 35% lower relative cardiovascular event rate in adults in the highest third for an inflammation marker.

Cohort · 3,914 peopleCardiovascular disease
AHA Scientific Sessions 2026 Abstract

Urinary cadmium linked to higher blood inflammation marker

Each increase spanning the middle half of urinary cadmium measurements was linked to 7.81% higher levels of a marker of chronic inflammation.Each increase spanning the middle half of urinary cadmium measurements was linked to 7.81% higher levels of a marker of chronic inflammation.

Cohort · 5,178 peoplePopulations
AHA Scientific Sessions 2026 Abstract

Enicepatide linked to lower abdominal fat markers across ages

At 48 weeks, waist circumference fell 11.6%, 12.4% and 14.3% at increasing enicepatide doses, compared with 1.5% with placebo.At 48 weeks, waist circumference fell 11.6%, 12.4% and 14.3% at increasing enicepatide doses, compared with 1.5% with placebo.

Randomized trial · 467 peopleInterventions
Journal of the American Heart Association

Urinary cadmium linked to higher immune marker levels

An increase in urinary cadmium spanning the middle half of measured levels was associated with 7.99% higher levels of an immune-activation marker.An increase in urinary cadmium spanning the middle half of measured levels was associated with 7.99% higher levels of an immune-activation marker.

Cohort · 5,148 peoplePopulations

See all 327 papers on Plasminogen